This October, Elsevier will be launching a unique
cross-discipline partnering event “Idea to IPO”, bridging universities with
industry as well as government, to focus on the commercialization of
university-based research.
This
two-day conference will provide a platform to explore the role of research in
innovation specifically from the European perspective. Plenary and parallel
sessions, including case study presentations from both the US and Europe, will
explore the challenges, risks and opportunities associated with researchers in
science and technology who are interested in entrepreneurial ventures. Specific
sessions will be dedicated to research commercialization across disciplines
related to Pharma, IT, and Clean-tech industries.
For
further information please visit http://www.idea2ipo-conference.com/index.html
We
look forward to your participation! Early bird registration rates are
available until July 26th.
No comments:
Post a Comment